Leerink Partners Maintains Outperform on Twist Bioscience, Lowers Price Target to $175

Benzinga · 20h ago
Leerink Partners analyst Puneet Souda maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and lowers the price target from $190 to $175.